Sipuleucel-T 50,000,000 CELLS in 250 mL Injection
RxNorm 997264
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 997264 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: sipuleucel-T 50,000,000 CELLS in 250 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
250 mL sipuleucel-T 200000 CELLS/ML Injection
(Atom ID: 7714284)
PSNPrescribable
Prescribable Name (PSN):
Sipuleucel-T 50,000,000 CELLS in 250 mL Injection
(Atom ID: 7710689)
SYPrescribable
Synonym (SY):
Sipuleucel-T 50,000,000 CELLS per 250 mL Injection
(Atom ID: 7710688)
Patient Education
Sipuleucel-T Injection
Sipuleucel-T injection is used to treat certain types of advanced prostate cancer. Sipuleucel-T injection is in a class of medications called autologous cellular immunotherapy, a type of medication prepared using cells from the patient's own blood. It works by causing the body's immune system (a group of cells, tissues, and organs that protects the body from attack by bacteria, viruses, cancer cells, and other substances that cause disease) to fight the cancer cells.
[Learn More]
* Please review the disclaimer below.